157 related articles for article (PubMed ID: 35399151)
1. Editorial: Preclinical Animal Models and Measures of Pain: Improving Predictive Validity for Analgesic Drug Development.
Tappe-Theodor A; Negus SS; Martin TJ
Front Pain Res (Lausanne); 2022; 3():867786. PubMed ID: 35399151
[No Abstract] [Full Text] [Related]
2. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.
Percie du Sert N; Rice AS
Br J Pharmacol; 2014 Jun; 171(12):2951-63. PubMed ID: 24527763
[TBL] [Abstract][Full Text] [Related]
3. Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
Le Cudennec C; Castagné V
Eur J Pharmacol; 2014 Jul; 735():17-25. PubMed ID: 24726848
[TBL] [Abstract][Full Text] [Related]
4. Animal models of pain: Diversity and benefits.
Abboud C; Duveau A; Bouali-Benazzouz R; Massé K; Mattar J; Brochoire L; Fossat P; Boué-Grabot E; Hleihel W; Landry M
J Neurosci Methods; 2021 Jan; 348():108997. PubMed ID: 33188801
[TBL] [Abstract][Full Text] [Related]
5. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics.
Nagakura Y
Drug Dev Res; 2018 Jun; 79(4):147-156. PubMed ID: 29732584
[TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain models in the development of analgesic drugs.
Honoré PH; Basnet A; Eljaja L; Kristensen P; Andersen LM; Neustrup S; Møllgaard P; Bjerrum OJ
Scand J Pain; 2011 Oct; 2(4):172-177. PubMed ID: 29913750
[TBL] [Abstract][Full Text] [Related]
7. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain.
Liang X; Yu G; Su R
Eur J Pharmacol; 2018 Mar; 823():27-34. PubMed ID: 29408090
[TBL] [Abstract][Full Text] [Related]
8. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
Taneja A; Della Pasqua O; Danhof M
Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
[TBL] [Abstract][Full Text] [Related]
9. Predictive validity of pharmacologic interventions in animal models of neuropathic pain.
Honoré PH; Basnet A; Kristensen P; Andersen LM; Neustrup S; Møllgaard P; Eljaja L; Bjerrum OJ
Scand J Pain; 2011 Oct; 2(4):178-184. PubMed ID: 29913756
[TBL] [Abstract][Full Text] [Related]
10. Animal models of chronic pain: Advances and challenges for clinical translation.
Burma NE; Leduc-Pessah H; Fan CY; Trang T
J Neurosci Res; 2017 Jun; 95(6):1242-1256. PubMed ID: 27376591
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
12. A large animal neuropathic pain model in sheep: a strategy for improving the predictability of preclinical models for therapeutic development.
Wilkes D; Li G; Angeles CF; Patterson JT; Huang LY
J Pain Res; 2012; 5():415-24. PubMed ID: 23166445
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.
Negus SS; Vanderah TW; Brandt MR; Bilsky EJ; Becerra L; Borsook D
J Pharmacol Exp Ther; 2006 Nov; 319(2):507-14. PubMed ID: 16751251
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research.
Fisher AS; Lanigan MT; Upton N; Lione LA
Front Pharmacol; 2020; 11():614990. PubMed ID: 33628181
[TBL] [Abstract][Full Text] [Related]
15. Intervertebral Foramen Injection of Ozone Relieves Mechanical Allodynia and Enhances Analgesic Effect of Gabapentin in Animal Model of Neuropathic Pain.
Luo WJ; Yang F; Yang F; Sun W; Zheng W; Wang XL; Wu FF; Wang JL; Wang JS; Guan SM; Chen J
Pain Physician; 2017 Jul; 20(5):E673-E685. PubMed ID: 28727712
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain.
Kim HK; Hwang SH; Lee SO; Kim SH; Abdi S
Pain Physician; 2016 May; 19(4):E589-600. PubMed ID: 27228525
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.
Sałat K; Furgała A; Sałat R
Inflammopharmacology; 2018 Apr; 26(2):361-374. PubMed ID: 29071457
[TBL] [Abstract][Full Text] [Related]
18. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
Stevenson GW; Cormier J; Mercer H; Adams C; Dunbar C; Negus SS; Bilsky EJ
Life Sci; 2009 Aug; 85(7-8):309-15. PubMed ID: 19559034
[TBL] [Abstract][Full Text] [Related]
19. Sigma-1 receptors and animal studies centered on pain and analgesia.
Davis MP
Expert Opin Drug Discov; 2015; 10(8):885-900. PubMed ID: 26037105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
